| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
October 9, 2020Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...
October 6, 2020Beckman Coulter, a clinical diagnostics leader, today announced research results that demonstrate its Access SARS-CoV-2 IgG assay shows excellent agreement to the Genscript SARS-CoV-2 Surrogate...
October 1, 2020Beckman Coulter today announced that it has received Emergency Use Authorization (EUA) for its Access Interleukin-6 (IL-6) assay from the U.S. Food & Drug Administration (FDA). Access IL-6 is a...
August 24, 2020Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay. The new IgM antibody test demonstrated 99.9% specificity against...
August 5, 2020Beckman Coulter today announced new analysis from the pivotal study of its novel monocyte distribution width (MDW) hematologic biomarker for sepsis detection. The analysis showed that abnormal MDW...
